← Back to headlines
Gilead to Acquire Arcellx for $7.8 Billion
Gilead Sciences has announced its intention to acquire Arcellx in a deal valued at $7.8 billion, expanding its portfolio in the biotechnology sector.
23 Feb, 11:12 — 23 Feb, 11:12
ℹOnly 1 source covers this story
